文章预览
BioVerse: R and Deal-making Trends in I 【Episode 013】 Introduction Highlights • Learn the key features that set inflammation & immunology (I ) apart from other disease areas . Understand the factors propelling the current boom in I research and development (R ) and deal-making. • Learn the emerging targets , novel modalities , and key disease areas in R and deal-making. • Discuss the factors that drive bispecific antibodies’ popularity in I • Debate which one, Car-T vs T-cell engager , is the better modality for autoimmune diseases . Speaker: David Shen, PhD Founder and CEO, Proteologix Inc. Kaveri Pohlman, PhD, MBA Senior Biotech Analyst David Gu, PhD CFO, EpimAb Biotherapeutics Host: Leon Tang, PhD ISWT Community & ISWT BioAdvisory Organizers: Partners & Collaborators: \ | / ★ Registration Date and Time: Wednesday, Sep 11th, 2024, 10-11 am (EST) Wednesday, Sep 11th, 2024, 10-11 pm (BJT) Register for the webinar here & submit yo
………………………………
